Droglican® - Chondroitin Sulfate 200 Mg / Glucosamine Hydrochloride 250 Mg Hard Capsules.
Bioiberica Spain flag Spain
Abstract ID:
The first association chondroitin / glucosamine authorized as drug in Europe.
Send an Inquiry
RE:
Participants
You
Droglican® is the first and only association chondroitin-glucosamine authorized as drug in Europe.
 

Indicated for the symptomatic treatment of osteoarthritis of the knee in patients suffering from moderate to severe pain due to osteoarthritis.

 

Authorized and commercialized in Spain.

 

Currently under registration in several countries of Europe.  Available for out-licensing.

 

 
Type of Business Relationship Sought
Out-licensing opportunity
FEATURED
Last Updated Mar 2017
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION

Opportunity Contact